BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4665 related articles for article (PubMed ID: 6431036)

  • 1. [A newly established melanoma cell line (GAK) with 5-S-cysteinyldopa phenotype].
    Nozawa S; Ohta H; Tsukazaki K; Udagawa Y; Kurihara S; Kano S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):883-92. PubMed ID: 6431036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice].
    Tuo CW; Zhang N; Liu QZ; Yang B; Wang MY
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):885-90. PubMed ID: 19173986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of nude mice liver metastatic model of human primary malignant melanoma of the small intestine].
    Tuo S; Zhang N; Liu QZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):348-53. PubMed ID: 18636357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of human vaginal malignant melanoma xenotransplants.
    Sawada M; Terada N; Nishizawa Y; Ito S; Wakamatsu K; Takemura K; Yamamoto T; Ozaki M; Sakamoto H; Tanizawa O
    Anticancer Res; 1994; 14(4A):1477-82. PubMed ID: 7526770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.
    Aubert C; Rougé F; Galindo JR
    J Natl Cancer Inst; 1980 May; 64(5):1029-40. PubMed ID: 6929009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastruct and biochemical chantes in cultured human malignant melanoma cells after heterotransplantation into nude mice.
    Aubert C; Chirieceanu E; Foa C; Rorsman H; Rosengren E; Rougé F
    Cancer Res; 1976 Sep; 36(9 pt.1):3106-12. PubMed ID: 975076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
    Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1977; 57(4):313-5. PubMed ID: 70922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
    Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
    Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
    Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free and bound 5-S-cysteinyldopa and dopa in human malignant melanomas.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1978; 58(3):270-2. PubMed ID: 78645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between differentiation and malignancy in human malignant melanocytes "in vivo" and "in vitro" (author's transl)].
    Foa C
    Bull Cancer; 1979; 66(3):235-58. PubMed ID: 114247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathionedopa in malignant melanoma.
    Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1977; 57(3):221-2. PubMed ID: 71825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
    Ito S; Wakamatsu K; Inoue S; Fujita K
    Acta Derm Venereol; 1989; 69(5):380-4. PubMed ID: 2572100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas.
    Marnot D; Decaux F; Berthelot P; Kalis B; Jardillier JC; Warren L
    Cancer Detect Prev; 1983; 6(1-2):303-10. PubMed ID: 6411338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis.
    Zhang RD; Price JE; Schackert G; Itoh K; Fidler IJ
    Cancer Res; 1991 Apr; 51(8):2029-35. PubMed ID: 1826230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells.
    Fodstad O; Kjønniksen I; Aamdal S; Nesland JM; Boyd MR; Pihl A
    Cancer Res; 1988 Aug; 48(15):4382-8. PubMed ID: 3390834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 234.